Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2003-7-22
pubmed:abstractText
Several drugs that primarily act on gamma-aminobutyrate or muscarinic receptors have been used to treat downbeat nystagmus (DBN) syndrome despite their having only moderate success and causing several side effects that limit their effectiveness. These drugs were tested under the assumption that DBN was caused by a disinhibition of a physiologic inhibitory cerebellar input on vestibular nuclei.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1526-632X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
22
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
165-70
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:12874393-4-Aminopyridine, pubmed-meshheading:12874393-Action Potentials, pubmed-meshheading:12874393-Aged, pubmed-meshheading:12874393-Aged, 80 and over, pubmed-meshheading:12874393-Cerebellum, pubmed-meshheading:12874393-Cross-Over Studies, pubmed-meshheading:12874393-Double-Blind Method, pubmed-meshheading:12874393-Female, pubmed-meshheading:12874393-Humans, pubmed-meshheading:12874393-Male, pubmed-meshheading:12874393-Middle Aged, pubmed-meshheading:12874393-Models, Neurological, pubmed-meshheading:12874393-Nystagmus, Pathologic, pubmed-meshheading:12874393-Potassium Channel Blockers, pubmed-meshheading:12874393-Potassium Channels, pubmed-meshheading:12874393-Prospective Studies, pubmed-meshheading:12874393-Purkinje Cells, pubmed-meshheading:12874393-Treatment Outcome, pubmed-meshheading:12874393-Vestibular Nuclei
pubmed:year
2003
pubmed:articleTitle
Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
pubmed:affiliation
Department of Neurology, University of Munich, Germany. mstrupp@nefo.med.uni-muenchen.de
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial